Correlation Between Kiromic Biopharma and Hillstream Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kiromic Biopharma and Hillstream Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiromic Biopharma and Hillstream Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiromic Biopharma and Hillstream Biopharma, you can compare the effects of market volatilities on Kiromic Biopharma and Hillstream Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiromic Biopharma with a short position of Hillstream Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiromic Biopharma and Hillstream Biopharma.

Diversification Opportunities for Kiromic Biopharma and Hillstream Biopharma

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between Kiromic and Hillstream is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Kiromic Biopharma and Hillstream Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hillstream Biopharma and Kiromic Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiromic Biopharma are associated (or correlated) with Hillstream Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hillstream Biopharma has no effect on the direction of Kiromic Biopharma i.e., Kiromic Biopharma and Hillstream Biopharma go up and down completely randomly.

Pair Corralation between Kiromic Biopharma and Hillstream Biopharma

If you would invest  39.00  in Hillstream Biopharma on October 24, 2024 and sell it today you would earn a total of  0.00  from holding Hillstream Biopharma or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Kiromic Biopharma  vs.  Hillstream Biopharma

 Performance 
       Timeline  
Kiromic Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kiromic Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Kiromic Biopharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Hillstream Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hillstream Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Hillstream Biopharma is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Kiromic Biopharma and Hillstream Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kiromic Biopharma and Hillstream Biopharma

The main advantage of trading using opposite Kiromic Biopharma and Hillstream Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiromic Biopharma position performs unexpectedly, Hillstream Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hillstream Biopharma will offset losses from the drop in Hillstream Biopharma's long position.
The idea behind Kiromic Biopharma and Hillstream Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon